Rivkin Anna 4
4 · Foghorn Therapeutics Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Rivkin Anna
Chief Business Officer
Transactions
- Award
Stock Options (Right to buy)
2024-09-03$7.85/sh+190,000$1,491,500→ 190,000 totalExercise: $7.85Exp: 2034-09-03→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on September 3, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.